A mitochondrial composition and its application, daily chemical product

The synergistic effects of hydrolyzed sodium hyaluronate, sodium heparin, glycerin, sodium mannose phosphate, mannose and trehalose in the mitochondrial composition are solved, and effective skin repair is achieved and anti-aging effects.

CN118436552BActive Publication Date: 2024-11-26MEYER BIO-MEDICINE CO LTD +1
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202410471016.4
Authority / Receiving Office
CN · China
Patent Type
Patents(China)
Current Assignee / Owner
Filing Date
2024-04-18
Publication Date
2024-11-26
Estimated Expiration
2044-04-18

AI Technical Summary

Technical Problem

The prior art is difficult to effectively promote mitochondrial autophagy and ATP generation, which makes it difficult to effectively solve the problem of skin aging.

Method used

By using a mitochondrial composition, including hydrolyzed sodium hyaluronate (HA20), sodium heparin and glycerol, water, sodium mannose phosphate, a mixture of mannose (M6P-LC) and trehalose, through the synergistic effect of these ingredients, Enhance the skin's moisturizing ability, antioxidant ability and autophagy cleaning ability, promote ATP production and mitochondrial health maintenance.

Benefits of technology

It significantly improves mitochondrial self-repair and autophagy cleaning capabilities, promotes the synthesis of ATP, delays the skin aging process, improves the skin's moisturization and elasticity, and reduces the appearance of wrinkles and fine lines.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure BDA0004798893480000041
    Figure BDA0004798893480000041
  • Figure BDA0004798893480000051
    Figure BDA0004798893480000051
  • Figure BDA0004798893480000061
    Figure BDA0004798893480000061
Patent Text Reader

Abstract

The present application belongs to the field of cosmetic production technology, and discloses a mitochondrial composition, which contains 0.01-1% HA20, 0.0001-1% heparin sodium, 0.1-2% trehalose, 0.01-1% M6P‑LC and the remainder of water by mass percentage, wherein HA20 can protect mitochondria under UV irradiation; heparin sodium protects mitochondrial damage and apoptosis of vascular endothelial cells; M6P‑LC can enhance the function of ATP synthase, and has both antioxidant and DPPH free radical scavenging effects, which is conducive to increasing ATP generation and maintaining mitochondrial health by activating the autophagy process; trehalose helps to maintain the integrity of the mitochondrial membrane structure, promotes the increase in ATP synthesis efficiency and the enhancement of transmembrane potential, and the mutual synergistic effect between the above components jointly enhances the self-repair and autophagy cleaning ability of mitochondria after damage. In addition, the present application also discloses the use of the above-mentioned mitochondrial composition and a daily chemical product.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention relates to the technical field of cosmetic production, and in particular to a mitochondrial composition and application thereof, and daily chemical products. Background Art

[0002] Skin aging is divided into endogenous aging caused by age and exogenous aging caused by factors such as sun exposure, environmental pollution, smoking, and lifestyle. Its key feature is the direct consequence of mitochondrial dysfunction. These aging phenotypes include wrinkles, graying and shedding of hair, uneven pigmentation, and slow wound healing. At the molecular level, the characteristics of aging skin are the loss of membrane potential in the dermis and epidermis, increased ROS levels, mitochondrial damage, DNA damage leading to nuclear and mtDNA mutations, respiratory chain defects caused by enzyme changes, cell regulation changes, and disease progression. In the 1950s, American scientist Harman proposed the free radical damage theory, believing that mitochondrial damage and dysfunction are the initial links of aging. High levels of ROS are cytotoxic and affect mitochondrial function as a byproduct of energy metabolism, causing damage to lipids, proteins, and DNA. Changes in mitochondrial quality and activity and the biosynthesis of electron transport chain complexes directly affect cell aging.

[0003] As we age, we will always encounter aging unexpectedly. In January 2023, a landmark review article Hallmarks of aging: An expanding universe was published in the top international academic journal Cell, which introduced the twelve major characteristics of aging. All twelve characteristics of aging are closely related to each other.

[0004] Among them, mitochondrial dysfunction has always been the main direction of aging research. Mitochondria are not only the power source of cells, but also triggers of inflammation (when reactive oxygen or mtDNA leaks from mitochondria, leading to the activation of inflammasomes or DNA sensors, respectively) and cell death factors (when caspase activators, nucleases or other lethal enzymes are released from the membrane space).

[0005] With aging, mitochondria become dysfunctional due to several mechanisms, including accumulation of mitochondrial DNA mutations, inadequate proteostasis, reduced organelle turnover, and changes in mitochondrial dynamics. Mitochondrial dysfunction impairs mitochondrial contribution to cellular bioenergetics, enhances reactive oxygen species production, and may trigger mitochondrial membrane hyperpermeability, leading to inflammation and cell death. Proper mitochondrial function is essential for maintaining health, and mitochondrial dysfunction contributes to aging.

[0006] Mitochondria are important components of cell structure, have multiple metabolic and signal transduction functions, are the bioenergetics center of eukaryotic cells, and are organelles that play a primary role in energy generation and oxidative stress.

[0007] Mitochondria not only provide more than 90% of the energy source for cells, but also deeply regulate energy metabolism, ROS and free radicals, oxidative stress, inflammation, wound healing, autophagy, calcium homeostasis, stem cells, tissue reconstruction, pigmentation, biological rhythms and hair growth. In addition, mitochondria are considered to be the main cause of cellular aging. Mitochondrial dysfunction leads to skin aging and damage, and targeting mitochondria helps restore skin vitality and accurately solve the problem of anti-aging.

[0008] Mitochondrial membrane potential refers to the potential difference between the inner and outer membranes of mitochondria. Mitochondrial membrane potential is regulated by ion channels and transport proteins on the inner and outer membranes, and plays an important role in maintaining mitochondrial function and energy metabolism. Under normal circumstances, mitochondrial membrane potential is generated during the electron transfer process between the inner and outer membranes of mitochondria through the respiratory chain complex. This electron transfer process interacts with the proton pump and ATP synthase to produce ATP. However, under external stimuli (such as UV irradiation), mitochondrial membrane potential may be lost / decreased, and the electron transfer process in mitochondria is disturbed, resulting in the production of more free radicals and ROS (reactive oxygen free radicals). This process may further trigger cell apoptosis pathways and have a negative impact on cell survival and function.

[0009] Mitophagy is a regulatory mechanism that maintains a balance between the quality and quantity of mitochondria in cells. It can remove dysfunctional or redundant mitochondria in a timely manner and is of great significance in maintaining cell homeostasis. PINK1 (PTEN-induced putative kinase protein 1) is a serine / threonine kinase and a key protein for the occurrence of mitophagy. Under normal conditions, PINK1 can enter the mitochondrial intermembrane space through the action of the translocase outer membrane (TOM) complex on the mitochondrial outer membrane, and then interact with the TIM (translocase inner membrane) complex on the inner membrane, and further transfer to the inner membrane of mitochondria, where it is degraded by presenilin-associated rhomboid like protein (PARL) on the inner membrane, which maintains its low expression level.

[0010] When mitochondria are in an aging state, the mitochondrial membrane potential decreases, the degradation of PINK1 slows down or disappears, and PINK1 accumulates on the outer membrane of mitochondria. Subsequently, Parkin in plasma also accumulates on damaged mitochondria, ubiquitinating mitochondrial anion channel protein VDAC1 (voltage dependent anion channel 1), fusion protease 2 (GTPase mitofusin 2, MFN2), etc., becoming a signal for inducing mitochondrial autophagy.

[0011] Chinese patent application 202111653139.2 discloses a skin care composition that is easy to absorb and can repair hormone face, and its application. The raw materials include, by weight: moisturizer, repair component, anti-allergic composition, and nutrient. The addition of moisturizer, repair component, anti-allergic composition, and nutrient in this scheme makes the resulting skin care composition easy to absorb, which can restore the normal function of the skin, adjust the skin structure and organization, and enhance the skin's metabolic function, and has a significant effect of repairing hormone face. Moreover, the resulting skin care composition also has the effects of whitening, moisturizing, anti-inflammatory, and antibacterial. At the same time, it can promote tissue regeneration, fade scars, tighten the skin, and delay skin aging to a certain extent, achieving both skin care and function;

[0012] Further observation of the instructions of the scheme shows that the moisturizer in the scheme is selected from one or more of erythritol, xylitol, serine, glycine, alanine, trehalose, aspartic acid, valine, maltose, arginine, isoleucine, glucose, leucine, fructose, glutamic acid, proline, sodium lactate, allantoin, betaine, sodium hyaluronate, vitamin B, glycerol, and butylene glycol;

[0013] In this solution, the nutrient is selected from one or more of vitamin E acetate, inositol, elastin, algae extract, collagen, allantoin, collagen peptide, milky cod liver oil, heparin sodium, Alsophila spinulosa leaf extract, and honey;

[0014] It can be seen from this that in this solution, sodium hyaluronate and trehalose are more used as moisturizing ingredients, while sodium heparin is added more as a nutrient ingredient.

[0015] Chinese patent application 202111538795.8 discloses a refreshing, moisturizing, whitening and anti-allergic skin care product and its application, which is prepared by mixing component A raw materials with component B raw materials at a specific temperature, stirring evenly, cooling to a specific temperature, adding component C raw materials one by one, stirring evenly and cooling to room temperature, and preparing a refreshing, moisturizing, whitening and anti-allergic skin care product with stable physical and chemical properties, excellent long-lasting moisturizing, whitening, soothing and repairing allergic skin, mild and non-irritating effects;

[0016] Further observation of the instructions of the scheme shows that component A in the scheme is composed of an alcohol compound, a viscosity control agent, a surfactant, a conditioning agent, and a sustained-release agent, wherein the conditioning agent includes one or a combination of allantoin, sodium hyaluronate, betaine, hydrolyzed sodium hyaluronate, trehalose, and sodium pyrrolidonecarboxylate;

[0017] And from the 46th paragraph of the scheme description, it can be seen that the scheme uses the synergistic effect of the three, the conditioner, the repair agent and the synergist. The active groups of the molecules with long-chain structure in the repair agent are tightly connected with the active groups in the synergist through intermolecular interactions, and their molecular chains are entangled with each other to form a coating structure, which tightly encapsulates the active ingredients in the formed coating structure, thereby improving the physical and chemical stability of the active ingredients. The two interact with the sodium hyaluronate with a long-chain structure and the allantoin and betaine with a short-chain structure in the conditioner through the active groups on the molecular chain, and through the intermolecular interactions between the long and short chains, the stability of the coating structure is further improved. It can be seen that if any one of the conditioner, the repair agent and the synergist in the scheme is missing, the synergistic effect among the three will be broken.

[0018] Chinese patent application 202310939814.0 discloses a soothing and anti-wrinkle composition. The soothing and anti-wrinkle composition disclosed in the scheme includes the following components in parts by weight: 0.0289-0.1020 parts of sodium mannose phosphate, 0.0128-0.0450 parts of mannose, 0.1000-0.2500 parts of peach resin extract, 8.4686-19.9260 parts of purslane extract, 0.0500-0.1200 parts of recombinant humanized type III collagen, 0.3500-1.0000 parts of hydroxypropyl tetrahydropyrantriol, and 0.0012-0.0060 parts of leech extract.

[0019] This solution selects sodium mannose phosphate, mannose, peach resin extract and other components to work synergistically to help improve fine lines and wrinkles and solve the problem of dark circles after staying up late; the composition is used to prepare soothing and anti-wrinkle eye masks, using biomagnetic eye masks and micro-thermal circulation technology to promote the full absorption of effective active ingredients.

[0020] The problem that this scheme needs to solve is: how to provide a mitochondrial composition that can promote the autophagy ability of mitochondria after damage and promote ATP generation. Summary of the invention

[0021] The purpose of the present invention is to provide a mitochondrial composition, which can promote the autophagy ability of damaged mitochondria and promote ATP generation, thereby clearing dysfunctional or redundant mitochondria in a timely manner.

[0022] To achieve the above objectives, the present application discloses a mitochondrial composition, which comprises the following components by mass percentage:

[0023]

[0024]

[0025] HA20 can absorb the surrounding water molecules to form a moisturizing film, effectively lock in moisture and prevent moisture loss, thereby keeping the skin hydrated. At the same time, HA20 can enhance the skin barrier function, improve the skin's protective ability, reduce the damage to the skin caused by external stimuli, and help the skin return to a healthy state. HA20 can also fill in fine wrinkles and blemishes on the skin surface, making the skin smoother and softer.

[0026] Heparin sodium has antioxidant properties, which can neutralize free radicals and reduce the damage of oxidative stress to the skin, thereby delaying the skin aging process. It can also promote the synthesis of collagen and elastin, improve skin elasticity, reduce the appearance of wrinkles and fine lines, and make the skin firmer. Heparin sodium has a strong moisturizing ability and can absorb and retain water molecules to form a moisturizing film, effectively locking in moisture and keeping the skin hydrated, which helps to improve problems such as dry and rough skin and make the skin softer and smoother.

[0027] Trehalose can absorb and retain water molecules, forming a moisturizing film that effectively locks in moisture and prevents water loss, thereby keeping the skin hydrated. This helps improve dry, tight skin and other problems, making the skin softer and more elastic. Trehalose also has certain anti-inflammatory properties, which can reduce the skin's inflammatory response and relieve discomfort symptoms such as redness and itching. In addition, trehalose also has certain antioxidant properties, which can neutralize free radicals, reduce oxidative stress damage to the skin, and help delay the skin aging process.

[0028] M6P-LC is a mixture of glycerol, water, sodium mannose phosphate, and mannose. It has certain antioxidant properties, can neutralize free radicals, and reduce the damage of oxidative stress to the skin. This helps protect the skin from environmental pollution and UV radiation, delays the skin aging process, and also has good moisturizing ability, can absorb and retain water molecules, forming a moisturizing film, effectively locking in moisture and preventing moisture loss;

[0029] Among the components disclosed in the present application, HA20 can protect mitochondria under UV irradiation; sodium heparin protects mitochondrial damage and apoptosis of vascular endothelial cells; M6P-LC can enhance the function of ATP synthase, and has both antioxidant and DPPH free radical scavenging effects, which is beneficial to increase ATP production and maintain mitochondrial health by activating the autophagy process; trehalose helps to maintain the integrity of the mitochondrial membrane structure, promotes the increase in ATP synthesis efficiency and the enhancement of transmembrane potential, and can effectively scavenge free radicals to protect mitochondria from oxidative damage. In addition, it can also promptly remove dysfunctional or excess mitochondria by initiating the autophagy mechanism.

[0030] Moreover, the synergistic effects among the above ingredients jointly enhance the self-repair and autophagy clearance capabilities of mitochondria after damage, while effectively promoting the synthesis of ATP.

[0031] Preferably, the following components are included:

[0032]

[0033] Preferably, the following components are included:

[0034]

[0035] In addition, the present application also discloses the use of the above-mentioned mitochondrial composition in preparing daily chemical products.

[0036] In addition, the present application also discloses a daily chemical product containing 0.1-5wt% of the above-mentioned mitochondrial composition.

[0037] Preferably, the daily chemical product is an aqueous solution, a cream, an emulsion or a spray.

[0038] Preferably, the daily chemical product is a gel, an essence, a toner, a facial mask, or a facial cleanser.

[0039] The beneficial effects of this application are:

[0040] In the mitochondrial composition disclosed in the present application, HA20 can protect mitochondria under UV irradiation; sodium heparin protects mitochondrial damage and apoptosis of vascular endothelial cells; M6P-LC can enhance the function of ATP synthase, and has both antioxidant and DPPH free radical scavenging effects, which is beneficial to increase ATP production and maintain mitochondrial health by activating the autophagy process; trehalose helps to maintain the integrity of the mitochondrial membrane structure, promotes the increase in ATP synthesis efficiency and the enhancement of transmembrane potential, and can effectively scavenge free radicals to protect mitochondria from oxidative damage. In addition, it can also promptly remove dysfunctional or excess mitochondria by initiating the autophagy mechanism.

[0041] Moreover, the synergistic effects among the above ingredients jointly enhance the self-repair and autophagy clearance capabilities of mitochondria after damage, while effectively promoting the synthesis of ATP. DETAILED DESCRIPTION

[0042] The present invention will be described clearly and completely below in conjunction with the embodiments of the present invention. In the description of the present invention, it should be noted that, if no specific conditions are specified in the embodiments, the conditions are carried out according to conventional conditions or conditions recommended by the manufacturer. If the manufacturer of the reagents or instruments used is not specified, they are all conventional products that can be purchased commercially.

[0043] Before presenting the examples, the following necessary descriptions are given of the basic information of the raw materials in the examples, wherein the raw materials, Chinese names, suppliers, and biological information are shown in Table 1:

[0044] Table 1

[0045]

[0046] It should be noted that M6P-LC is a mixture of glycerol, water, sodium mannose phosphate and mannose, and the mass ratio of glycerol, water, sodium mannose phosphate and mannose is 50:45.1:3.4:1.5.

[0047] At the same time, it needs to be further explained that in the embodiments and comparative examples, the preparation method of the mitochondrial composition is:

[0048] Step 1: Clean and sterilize the necessary equipment, accurately weigh the raw materials of each component in the composition, and place them in clean and sterilized containers for later use.

[0049] Step 2: Add the raw materials HA20 and trehalose into a water pot, stir and heat to 80-85°C, stir until completely dissolved, and start cooling.

[0050] Step 3: Lower the temperature to 45°C, add raw heparin sodium and M6P-LC respectively, and stir until completely dissolved.

[0051] Step 4: Take samples to test various physical and chemical indicators, and filter out the material after passing the test.

[0052] Examples 1-5

[0053] A mitochondrial composition, the formula of which is shown in Table 2:

[0054] Table 2

[0055]

[0056] It should be noted that the above HA20 is a full molecular weight hydrolyzed sodium hyaluronate with an average molecular weight of 200 KDa, and includes low molecular weight hydrolyzed sodium hyaluronate, medium molecular weight hydrolyzed sodium hyaluronate, and high molecular weight hydrolyzed sodium hyaluronate.

[0057] Comparative Examples 1-4

[0058] A composition, the formula is shown in Table 3:

[0059] Table 3

[0060]

[0061] Comparative Examples 5-11

[0062] A composition, the formula is shown in Table 4:

[0063] Table 4

[0064]

[0065]

[0066] It should be noted that the above HA60 is a full molecular weight hydrolyzed sodium hyaluronate with an average molecular weight of 600KDa, and includes low molecular weight hydrolyzed sodium hyaluronate, medium molecular weight hydrolyzed sodium hyaluronate, and high molecular weight hydrolyzed sodium hyaluronate;

[0067] The hydrolyzed sodium hyaluronate is a low molecular weight hydrolyzed sodium hyaluronate with an average molecular weight of 200 KDa.

[0068] Performance Test:

[0069] 1. Experimental reagents:

[0070] Human primary dermal fibroblasts and culture medium were purchased from Cell Technology; Penicillin-Streptomycin-Amphotericin B solution was purchased from Bioind, DPBS was purchased from Gibco, and CCK reagent was purchased from Tongren Bio; 6-well plates, 12-well plates, and 96-well cell culture plates were purchased from Thermo Fisher; tissue fixative, anhydrous ethanol (Sinopharm Group, catalog number 10009218), mitochondrial membrane potential detection kit (Beyotime, catalog number C1073M), Luminescent Cell Viability Assay (Promega, Catalog No. G7571), recombinant Anti-PINK1 antibody (Abcam, Catalog No. ab216144), Anti-Parkin antibody (Abcam, Catalog No. ab77924), Anti-LC3B antibody (Abcam, Catalog No. ab63817), Anti-BNIP3 antibody (Abcam, Catalog No. ab109362) and Anti-β-Actin antibody (Abcam, Catalog No. ab8226) were purchased from Abcam, USA; Triton X-100 (9002-93-1), SDS-PAGE protein 5× loading buffer (Beyotime, Catalog No. P0015L), RIPA lysis buffer (Beyotime, Catalog No. P0013B), protease inhibitor cocktail (Beyotime, Catalog No. P1005), BeyoECL Plus (ultrasensitive ECL chemiluminescence kit) (Beyotime, Catalog No. P0018S).

[0071] 2. Experimental equipment:

[0072] Cell culture incubator, inverted microscope, upright fluorescence microscope, biological safety cabinet, microplate reader, protein vertical electrophoresis instrument, chemiluminescent gel imager.

[0073] 3. Sample preparation:

[0074] The compositions prepared in the examples and comparative examples were diluted with deionized water to obtain multiple groups of samples. During the dilution process, the mass ratio of the composition to deionized water was 3:97. In the obtained samples, the mass fraction of the composition was 3%.

[0075] 4. Experimental methods:

[0076] 1. Human primary dermal fibroblast activity test: Human primary dermal fibroblasts were expanded and cultured using fibroblast culture medium under the culture conditions of 5% CO2 and 37°C. When the cells grew to 80-90% confluence, they were digested with trypsin and inoculated into 96-well plates. After the cells were attached and cultured in a 96-well plate for 48 hours, the diluted composition was used as a sample, and the cells were treated with the sample to obtain a corresponding sample group. At the same time, the cells were treated with the same amount of deionized water as the sample group to obtain a control group. After 48 hours, CCK-8 reagent was added according to the instructions and incubated for 1 hour, and the OD value was read at 450nm using a microplate reader. The relative cell activity value was obtained by calculating the ratio of the average OD values ​​of the sample group and the control group to determine the cytotoxic effect of the sample;

[0077] The relative cell activity was calculated as shown in formula (1):

[0078] Relative cell activity % = (OD value of sample group / OD value of control group) * 100% (Formula 1)

[0079] Table 5

[0080]

[0081] 2. ATP detection experiment

[0082] Human primary dermal fibroblasts were cultured in fibroblast medium at 5% CO2 and 37°C. When the cells grew to 80-90% confluence, they were digested with trypsin and seeded in 96-well plates. The cells were treated with samples overnight and then irradiated with UVA 10J / cm 2 After inducing cell damage, the samples were treated for 24 h and the amount of ATP generated in each group was detected.

[0083] The test results are shown in Table 6:

[0084] Table 6

[0085]

[0086]

[0087] It should be noted that the blank control group was not treated with UVA10J / cm 2 The damaged cells were not treated with samples. The UVA group was treated with UVA 10J / cm 2 Damaged cells that have not been treated with the sample.

[0088] 3. Mitochondrial membrane potential staining experiment

[0089] Human primary dermal fibroblasts were cultured in an incubator at 37°C, 5% CO2, and saturated humidity. After the cells grew to more than 80% confluence, they were digested and inoculated into 12-well plates and continued to be cultured for 48 hours for testing. The cells were first treated with the sample overnight, and then UVA 10J / cm 2 Induce cell damage, and then continue to treat with samples for 24 hours. Aspirate the cell culture medium and add PBS to wash once. Add 200μl detection buffer according to the instructions of the detection kit and mix gently. Incubate at room temperature (20-25℃) in the dark for 30 minutes. Then observe and take pictures under a fluorescence microscope, and use Image J to quantify the fluorescence signal.

[0090] The test results are shown in Table 7:

[0091] Table 7

[0092]

[0093]

[0094] It should be noted that the blank control group was not treated with UVA10J / cm 2 The damaged cells were not treated with samples. The UVA group was treated with UVA 10J / cm 2 Damaged cells that have not been treated with the sample.

[0095] 4. Western blot to detect the expression of autophagy-related proteins

[0096] Human primary dermal fibroblasts were cultured in fibroblast medium under the conditions of 5% CO2 and 37°C. When the cells grew to 80-90% confluence, they were digested with trypsin and inoculated in 6-well plates. The culture was continued for 48 hours. After the cells in the 6-well plates were treated, the medium was discarded, and the cells were washed 3 times with pre-cooled PBS. The PBS was aspirated and RIPA lysis buffer was added, and protease inhibitors were added at a ratio of 1:100; shake on ice for 20 seconds, scrape the cells with a cell scraper, transfer the liquid and cells to a 1.5mL EP tube, centrifuge at 4°C for 10 minutes, and transfer the supernatant to a new EP tube. Prepare each group of proteins into 2μg / μL loading buffer, denature the protein in a 100°C metal bath for 20 minutes, and store at -80°C. Prepare acrylamide gel, add 30 μg sample to each well, electrophoresis at 80V for 30min, 100V for 120min, use 0.22μm PVDF membrane, 200mA, 4℃ wet transfer for 90min; block with 5% skim milk (prepared with TBST) at room temperature for 1h, dilute PINK1 and LC3B antibodies at 1:1000, dilute β-actin at 1:5000, incubate overnight on a shaker at 4℃, aspirate and discard the primary antibody, wash 3 times with TBST, 10min each time, dilute the secondary antibody at 1:10000, incubate on a shaker at 37℃ for 1h, aspirate and discard the secondary antibody, wash 3 times with TBST, 10min each time, prepare the developer at 1:1, analyze with a gel imager, and analyze the quantitative protein expression with Image J.

[0097] The test results of PINK1 expression are shown in Table 8:

[0098] Table 8

[0099] Group AVE SD P-value Blank group 100.00% 18.98% - Example 1 253.18% 13.58% 0.0003 Example 2 215.03% 10.39% 0.0006 Example 3 189.03% 13.77% 0.0026 Example 4 180.96% 14.53% 0.0042 Example 5 239.01% 10.79% 0.0065 Comparative Example 1 127.08% 8.21% 0.0670 Comparative Example 2 121.77% 14.55% 0.1892 Comparative Example 3 131.75% 13.76% 0.0764 Comparative Example 4 123.11% 12.70% 0.1461 Comparative Example 5 161.96% 10.72% 0.0065 Comparative Example 6 138.08% 13.32% 0.0030 Comparative Example 7 136.75% 13.38% 0.0493 Comparative Example 8 136.42% 12.52% 0.0460 Comparative Example 9 154.10% 15.08% 0.0184 Comparative Example 10 146.75% 11.35% 0.0185 Comparative Example 11 142.08% 10.51% 0.0234

[0100] Result analysis:

[0101] 1. As can be seen from Table 5, the compositions prepared in the examples of the present application have little effect on cell activity and are non-cytotoxic;

[0102] 2. It can be seen from Examples 1-5 that when the addition amount of HA20 is 0.05%, the addition amount of heparin sodium is 0.001%, the addition amount of trehalose is 0.875%, and the addition amount of M6P-LC is 0.25%, the composition prepared in Example 5 has a relatively higher ATP generation, membrane potential expression, and PINK1 expression. It can be seen that the formula disclosed in Example 1 is significantly more advantageous than other examples;

[0103] Further, in combination with Table 6, it can be seen from Example 1 and Comparative Examples 1-4 that when HA20, sodium heparin, trehalose, and M6P-LC in Example 1 are omitted in turn in Comparative Examples 1-4, the relative ATP contents of Comparative Examples 1-4 are 128.5%, 126.1%, 132.8%, and 127.4%, respectively. Based on the difference between the ATP contents of Comparative Examples 1-4 and the UVA group, we can calculate that when HA20, sodium heparin, trehalose, and M6P-LC are present at the same time, the theoretical value of the ATP content should be about 138.2%, but the relative ATP content of Example 1 reaches 181.7%. Therefore, we believe that a certain synergistic effect is produced between HA20, sodium heparin, trehalose, and M6P-LC, and Example 1 achieves a good effect exceeding the theoretical value of the ATP content under the promotion of this synergistic effect;

[0104] It should be noted that in the above content, when HA20, heparin sodium, trehalose and M6P-LC are present at the same time, the calculation method of the theoretical value of ATP content is:

[0105] It is known that the relative ATP content of heparin sodium, trehalose, and M6P-LC is 128.5% when they are present simultaneously;

[0106] When HA20, trehalose, and M6P-LC were present simultaneously, the relative ATP content was 126.1%;

[0107] When HA20, heparin sodium, and M6P-LC were present simultaneously, the relative ATP content was 132.8%;

[0108] When HA20, heparin sodium, and trehalose were present simultaneously, the relative ATP content was 127.4%;

[0109] And the relative ATP content of the UVA group was 100.0%;

[0110] It can be inferred that the co-existence of heparin sodium, trehalose, and M6P-LC increased the relative ATP content by 28.5%.

[0111] When HA20, trehalose, and M6P-LC were present simultaneously, the relative ATP content increased by 26.1%;

[0112] When HA20, heparin sodium, and M6P-LC were present simultaneously, the relative ATP content increased by 32.8%;

[0113] When HA20, heparin sodium, and trehalose were present simultaneously, the relative ATP content increased by 27.4%;

[0114] That is, 3 (HA20 + sodium heparin + trehalose + M6P-LC) = 114.8%, so when HA20, sodium heparin, trehalose, and M6P-LC are present at the same time, the theoretical value of the relative ATP content should be 138.2%;

[0115] At the same time, further combined with Table 7 and using the above method to calculate the theoretical value of the relative expression of membrane potential in Example 1 should be 607%, but the actual value of the relative expression of membrane potential in Example 1 reached 1157%. It can be seen that in terms of membrane potential expression ability, HA20, heparin sodium, trehalose, and M6P-LC also have a synergistic effect to promote the composition to obtain a more excellent ability to promote membrane potential expression;

[0116] The theoretical value of INK1 expression in Example 1 calculated by the above calculation method in combination with Table 8 is 134.57%, but the actual value of PINK1 expression in Example 1 reaches 253.18%. It can be seen that in terms of PINK1 expression, HA20, sodium heparin, trehalose, and M6P-LC also have a synergistic effect to promote the composition to obtain a better ability to promote PINK1 expression;

[0117] 3. Combining Tables 6-8 and observing Example 1 and Comparative Examples 5-11, it can be seen that when any of HA20, heparin sodium, trehalose, and M6P-LC is replaced with a substance in the art that has a similar effect to HA20, heparin sodium, trehalose, and M6P-LC, the ability of the composition to promote ATP generation, membrane potential expression, and PINK1 expression all decreases to varying degrees. This shows that in the formula described in the present application, any component is irreplaceable.

Claims

1. A mitochondrial composition, characterized in that: Calculated by mass percentage, it includes the following components: HA20 0.0125~0.2%; Heparin sodium 0.00025~0.5%; Trehalose 0.22~1%; M6P-LC 0.062~1%; Deionized water was added until the total mass percentage reached 100%; The M6P-LC is a mixture of glycerol, water, sodium mannose phosphate, and mannose, and the mass ratio of glycerol, water, sodium mannose phosphate, and mannose is 50:45.1:3.4:1.5; The HA20 is a full molecular weight hydrolyzed sodium hyaluronate with an average molecular weight of 200 KDa, and includes low molecular weight hydrolyzed sodium hyaluronate, medium molecular weight hydrolyzed sodium hyaluronate, and high molecular weight hydrolyzed sodium hyaluronate.

2. The mitochondrial composition according to claim 1, characterized in that Includes the following components: HA20 0.0125~0.05%; Heparin sodium 0.00025~0.001%; Trehalose 0.22~0.875%; M6P-LC 0.062~0.25%; Deionized water was added to reach a total mass percentage of 100%.

3. Use of the mitochondrial composition according to any one of claims 1 to 2 in preparing daily chemical products.

4. A daily chemical product, characterized in that: Containing 0.1-5wt% of the mitochondrial composition according to any one of claims 1-2.

5. The daily chemical product according to claim 4, characterized in that: The daily chemical products are water-based solutions, creams, lotions, and sprays.

6. The daily chemical product according to claim 4, characterized in that: The daily chemical products are gel, essence, toner, facial mask and cleanser.